Cure My Disease

Don't miss your cure!

 Log in / Sign up

Second chance at breast preservation: new study tests repeat radiation

NCT ID NCT06704659

Recruiting now Disease control Sponsor: Turku University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study explores whether women with recurrent breast cancer can safely have breast-conserving surgery and a second round of radiation instead of full mastectomy. It will enroll 60 patients who had prior radiation at least 3 years ago and have small, localized tumors. The goal is to see if this approach is safe and maintains quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
radiation therapy
What this could lead to
If successful, this could offer a breast-sparing treatment option for women with recurrent breast cancer, avoiding full mastectomy.
What could go wrong
This is a small, early-phase study with only 60 participants, and repeat radiation carries risks of tissue damage and complications. It may not be safe or effective for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT BREAST CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast carcinoma breast neoplasm Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECURRENT BREAST CARCINOMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Helsinki University Hospital

    RECRUITING

    Helsinki, Finland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Turku University Hospital

    RECRUITING

    Turku, Finland

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.